Concussion Market, By Assessment Methods (Diagnosis (Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scans, Electroencephalography (EEG), X-rays, and Others) and Treatment (Medications)), By End Users (Hospitals, Diagnostic centers, Neurologic

Concussion Market, By Assessment Methods (Diagnosis (Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scans, Electroencephalography (EEG), X-rays, and Others) and Treatment (Medications)), By End Users (Hospitals, Diagnostic centers, Neurologic clinics, and Research institutions), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

The global concussion market is expected to witness significant growth over the forecast period owing to the rising incidence of sports-related head injuries and increasing awareness about concussion diagnosis and management. A concussion is a type of traumatic brain injury caused by a blow or jolt to the head that disrupts normal brain functioning. Symptoms may include headache, dizziness, fatigue, sleep disturbances, and difficulty concentrating. While most people recover from a concussion within weeks, repeated concussions over time can lead to long-term effects. Therefore, prompt diagnosis and appropriate treatment of concussions is important to prevent severe consequences.

Market Dynamics:

The global concussion market is primarily driven by the rising prevalence of head injuries during sports and recreational activities. Growing participation in contact sports such as American football, soccer, rugby, and mixed martial arts has led to high risk of concussions. In August 2024, according to Centers for Disease Control and Prevention (CDC) estimates, over 900,000 people in the U.S. visit the emergency room due to sports and recreation-related concussions annually. Moreover, increasing awareness about the long-term effects of multiple concussions is encouraging athletes and sports clubs to focus on the diagnosis and management of concussions. However, lack of awareness in developing regions and unavailability of advanced diagnostic tools in rural areas are some of the factors expected to restrain market growth to a certain extent. Development of novel diagnostic biomarkers and mobile apps for self-assessment present lucrative opportunities in the global concussion market.

Key Features of the Study:

• This report provides in-depth analysis of the global concussion market and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global concussion market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Nihon Kohden Corporation, Integra LifeSciences, Compumedics Limited, BioDirection (NanoDx), Oculogica, Abbott Laboratories, BrainScope Company Inc., Magstim, BIOMÉRIEUX S.A., Advanced Brain Monitoring, Inc., Healius Limited, Siemens Healthineers, GE Healthcare, Philips Healthcare, and Medtronic plc
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global concussion market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global concussion market

Market Segmentation

• Assessment Methods Insights (Revenue, USD Bn, 2019 - 2031)
• Diagnosis
• Magnetic Resonance Imaging (MRI)
• Computed Tomography (CT) scans
• Electroencephalography (EEG)
• X-rays
• Others
• Treatment
• Medications
• Rehabilitation therapies
• Surgical interventions
• End Users Insights (Revenue, USD Bn, 2019 - 2031)
• Hospitals
• Diagnostic centers
• Neurologic clinics
• Research institutions
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa
• Key Players Insights
• Nihon Kohden Corporation
• Integra LifeSciences
• Compumedics Limited
• BioDirection (NanoDx)
• Oculogica
• Abbott Laboratories
• BrainScope Company Inc.
• Magstim
• BIOMÉRIEUX S.A.
• Advanced Brain Monitoring, Inc.
• Healius Limited
• Siemens Healthineers
• GE Healthcare
• Philips Healthcare
• Medtronic plc